The capacity of lipopolysaccharide (LPS), zymosan, and calcium ionophore A23187 to induce neutrophil chemotactic activity (NCA), leukotriene B4 (LTB4), and neutrophil attractant/activation protein (NAP-1) release from human alveolar macrophages (AM) retrieved from normal nonsmokers was evaluated. LPS induced a dose-dependent release of LTB4 that began by 1 h, 4.0±3.2 ng/106 viable AM; peaked at 3 h, 24.7±13.5 ng/10' viable AM; and decreased by 24 h, 1.2±1.0 ng/106 viable AM (n = 8). Quantities of LTB4 in cell-free supernatants of AM stimulated with LPS were determined by reverse-phase high-performance liquid chromatography and corresponded well with results obtained by radioimmunoassay. By contrast, NAP-I release began -3-5 h after stimulation of AM with LPS, 197±192 ng/ml, and peaked at 24 h, 790±124 ng/ml. Release of NAP-1 was stimulus specific because A23187 evoked the release of LTB4 but not NAP-1, whereas LPS and zymosan induced the release of both LTB4 and NAP-1. The appearance of neutrophil chemotactic activity in supernatants of AM challenged with LPS for 3 h could be explained completely by the quantities of LTB4 present. After 
Introduction
Alveolar macrophages (AM)' reside on the epithelial surfaces of human large airways (1, 2) and alveoli (3) . These cells serve several functions which include important roles in host lung defense (4, 5) and in inflammatory processes central to several lung diseases (3, 6) . Macrophages release an impressive array of biologically active molecules (7) among which are molecules with the ability to direct the migration of neutrophils to the lung.
Leukotriene B4 (5S, 1 2R)-dihydroxy-(6Z,8E, lOE, 14Z)-eicosatetraeonic acid (LTB4) is one human AM product (8) (9) (10) (11) (12) (13) with numerous effects on a variety ofleukocytes. Of particular interest are the effects of LTB4 on human neutrophils. These include potent chemokinetic and chemotactic activity (14-17), induction ofaggregation ( 15), and stimulation ofneutrophil lysosomal enzyme release (18) . Another human AM product with a profound ability to modulate neutrophil function is a recently isolated (19, 20) , sequenced (21) (22) (23) , and cloned (24) 72-residue neutrophil attractant/activation protein (NAP-1), which is also referred to as NAP-1/IL-8.2 Both NAP-I that is generated from lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes (19) and recombinant NAP-I are potent chemotaxins for human neutrophils (25) .
Whereas human AM release significant quantities of LTB4 within minutes after stimulation with A23187 (8, (10) (11) (12) (13) 26) or zymosan (26) and large amounts of NAP-I by 24 h after stimulation with LPS (27) , we hypothesized that A23 187, zymosan, and LPS would elicit the release of LTB4 first and at later time points NAP-1, and that each of these neutrophil chemotaxins might contribute, at junctures consistent with their time course of release, to the overall neutrophil chemotactic activity present in supernatants of purposefully stimulated AM. Our results demonstrate that AM release of these two neutrophil chemotaxins is stimulus specific, that AM release of LTB4 and NAP-1 occurs in sequence, and that AM effectively metabolize LTB4 over 24 h to at least five products separable by reverse-phase high-performance liquid chromatography (RP-HPLC). The combined ability of the macrophage to release sequentially LTB4 and NAP-1, and the ability of this cell to regulate extracellular concentrations of LTB4, provide this effector cell with a graded flexibility to effect neutrophil movement to the lung. lavage (BAL) as described in detail (1 1). Briefly, no subject admitted to any acute or chronic illness, none was taking any regular medication other than birth control pills, and none admitted to an acute respiratory tract illness in the 4-wk period before participation. All subjects had normal spirometry and chest roentgenograms. Topical 4% lidocaine was used to anesthetize the oropharynx. BAL then was performed through a fiberoptic bronchoscope, wedged in a segmental bronchus, by instilling pyrogen-free sterile normal saline in 50-ml aliquots and gently aspirating after each instillate. A maximum of250 ml was instilled into each lung. BAL aliquots then were pooled, filtered through a single layer of gauze, and centrifuged at 500 g for 5-10 min at 240C. The cells were washed one to two times in Ca2`-and Mg2+-free Hanks' balanced salt solution (HBSS, Grand Island Biological Co., Grand Island, NY) and resuspended in LPS-free RPMI-1640 containing 1% fetal bovine serum, 2 mM L-glutamine, and 50 ug/ml ofgentamicin sulfate at 2 X 106 cells per ml. Cell viability was determined by the exclusion of Trypan blue. The total number of cells was enumerated on a hemacytometer, and differential cell counts were performed on cytocentrifuge preparations stained with Diff-Quik (American Scientific Products, McGaw Park, IL). Lavage cells prepared in this fashion totaled (mean±SD) 85.1±19.0% AM, 9.3±4.7% lymphocytes, 0.7±0.7% neutrophils, and 0.3±0.4% eosinophils (n = 23). Macrophage viability prior to adherence averaged 88.2±4.6%; red blood cell contamination averaged 8.0±3.7%. Platelet contamination, estimated from the small number of red blood cells in the lavage fluids never exceeded one platelet per nucleated cell. One million cells then were added to sterile 24-well culture plates (Costar, Cambridge, MA) and adhered for 1 h before the nonadherent cells were removed gently with a single wash of medium. The cells then were covered with 0.5 ml of medium.
Preparation ofAM stimuli. A23187 was purchased from Calbiochem-Behring Corp., La Jolla, CA, dissolved in DMSO, diluted to 200 AM in HBSS, and stored at -70'C. Nordihydroguiaretic acid (NDGA), purchased from Sigma Chemical Co., St. Louis, MO, was resuspended in ethanol at 10-2 M and stored at -70'C.
Zymosan (Sigma Chemical Co.) particles were prepared by suspending them in endotoxin-free normal saline and boiling for 1 h. The particles were centrifuged at 100 g for 10 min to remove any aggregates. The remaining particles were counted in a counter (Coulter Electronics, Inc., Hialeah, FL) and adjusted to a concentration that resulted in a ratio of -50 particles per macrophage in the AM cultures. Soluble fl-D-glucan (Laminarin, Sigma Chemical Co.) was resuspended at 5 mg/ml in culture medium and stored at -70°C.
LPS, Escherichia coli LPS 055:B5, purchased from Difco Laboratories, Inc., Detroit, MI, was resuspended in the RPMI-1640 medium used for the cell cultures at a concentration of 1 mg/ml.
Quantitation of NAP-I. NAP-I was quantified using a sandwich enzyme-linked immunosorbent assay (ELISA). The production, cloning, assay, and purification of mouse monoclonal IgG anti-NAP (28) and other details of the assay have been described previously (27) . Mouse monoclonal anti-NAP-I was used as capture antibody at a concentration of 9 gg/ml. Nonspecific binding was prevented by 0. 1% bovine serum albumin. Polyclonal rabbit anti-NAP-l was used as detection antibody. After incubation with alkaline phosphatase-conjugated goat anti-rabbit IgG (Sigma Chemical Co.), we used the ELISA Amplification System (Bethesda Research Laboratories, Gaithersburg, MD) to increase sensitivity. Serial NAP-l dilutions were applied to each plate as a reference standard. Absorbance (27 The dose dependency of LPS-induced LTB4 release was determined using concentrations ranging from 2 ng to 20 Ag/ml on AM incubated for 3 h at 37°C (Table I ). The LPS dose response of LTB4 release, as determined by RIA, was progressive up to a concentration of 2 ,ug/ml and plateaued.
LPS-and zymosan-induced NCA, LTB4, and NAP-1 release. Duplicate cultures of AM were challenged with either LPS (10 ttg/ml) or zymosan (particle/AM ratio of 50:1) for time periods from 0.1 to 24 h. Neutrophil chemotactic activity (NCA), LTB4, and NAP-1 were determined on aliquots of duplicate samples. Neutrophil chemotactic activity increased rapidly in supernatants from AM stimulated with each sub- Determination if chemotactic activity in 3-h LPS-stimulated AM culture fluids was attributable completely to LTB4.
AM were stimulated for 3 h at 370C with 10 jig/ml of LPS (n = 3), and LTB4 concentrations in these supernatants were determined by RIA. The neutrophil chemotactic activity of synthetic LTB4 and that of three serial dilutions of an aliquot of supernatants from LPS-stimulated AM then was determined (Fig. 3) . These data suggest that all of the neutrophil chemotactic activity present in supernatants of AM challenged with LPS for 3 h could be accounted for by the quantities of LTB4 present. A23187-induced release of NCA, LTB4, and NAP-I. Duplicate cell cultures were incubated with A23187 for time points from 0.1 to 24 h, and aliquots of the AM supernatants were assessed for NCA, LTB4, and NAP-1. AM release of NCA, LTB4, and NAP-1 in response to A23187 contrasted markedly with that observed from AM stimulated with either LPS or zymosan (Fig. 4) . The NCA present in supernatants from AM stimulated with A23187 was greater at the 0.1-h time point than that in the 0.1-h time points from cells stimulated with LPS or zymosan. This was associated with the presence of relatively large quantities LTB4 in the supernatants of A23187-stimulated AM, 11.1±3.7 ng/106 viable AM (14.6±8.1 ng/ml), relative to the concentrations of LTB4 present in the 0.1-h time points ofAM stimulated with zymosan or LPS, which never exceeded 1.1±0.3 ng/ 106 viable AM. In contrast to results obtained from experiments using either LPS or zymosan as stimuli, the time-response curve for the generation of NCA induced by A23187 peaked at 0.5 h and declined slowly but progressively over the subsequent 24 h. The timeresponse curve for the release of LTB4 closely paralleled the NCA response curve. However, NCA and significant quantities of LTB4, 30 
Discussion
The results of this study firmly establish several new findings. First, they prove that LPS E. coli 055:B5 will elicit the timedependent release of LTB4 from normal, adhered human AM cultured in vitro. The quantities of LTB4 determined by RP-HPLC closely approximated amounts assessed at each time point by RIA. Mean LTB4 release, as determined by RIA, at the 3-h time point was 24.7±13.5 ng/106 viable AM with a range of 7.5-45 ng/106 viable AM which corresponds to concentrations of -2 X 10-8 M to 1.3 X i0-7 M. These concentrations are functionally significant, considering that concentrations of 3 X 10-9 M LTB4 are chemotactic for neutrophils ( Fig. 3 and reference 29) . Importantly, LPS in concentrations as low as 2 ng/ml were an effective stimulus for LTB4 release. The amounts ofLPS utilized in our studies were in the range of LPS quantities detected in the plasma of patients with sepsis (30) . LTB4 has been identified in increased concentrations in the BAL fluid of both patients with the adult respiratory distress syndrome (ARDS) and those at risk for developing it (31). We have observed previously (27) and confirmed in this study that LPS also is a potent stimulus for NAP-I release. Collectively, these observations support the hypothesis that during sepsis circulating endotoxin activates lung macrophages-possibly by binding to one or more of the LPS-binding proteins present on macrophages (32, 33)-to release LTB4 and NAP-1, which subsequently recruit neutrophils to the lung. The above data differ from those of Brown and colleagues (34) who determined that normal human AM release only cyclooxygenase products after challenge with endotoxin. Luderitz and co-workers (35) have established that different LPS vary in their capacity to effect leukotriene release from mouse peritoneal macrophages. Thus, the difference between the findings of Brown and co-workers and those of our study possibly may be explained in part, by the use of a different serotype of LPS and/or by other undefined conditions. Secondly, our data reveal that LPS-stimulated AM release LTB4 and NAP-1 in sequence. LTB4 release commenced first at -1 h and peaked by 3 h. The amount of LTB4 present in supernatants of AM stimulated for 24 h was not significantly different from that quantitated in the supernatants of cells not purposefully stimulated. By contrast, LPS-elicited AM release of NAP-I began between 3 and 5 h after challenge and was maximum at the last time point tested, 24 h (Fig. 2 A) . We have shown previously by ELISA, HPLC-CM elution pattern, and NH2-terminal sequence analysis that the NAP present in the 24-h supernatants ofLPS-stimulated normal, adhered AM is identical to that released by normal human peripheral blood monocytes (27) .
The time-response curve of LTB4 release induced by zymosan was similar to that observed with LPS. Human monocytes possess a receptor for j3-glucans (36) . Zymosan activation of this receptor on human peripheral blood monocytes results in the generation and release of LTB4 and LTC4 (37) . The active constituent of zymosan particles that elicits leukotriene release is ,B-glucan (36) . Soluble ,B-glucans inhibit monocyte phagocytosis of zymosan and deminish LTB4 release by these cells by -60-70% (37) . We observed a similar inhibitory effect (mean of 40%, n = 4) by soluble f,-glucans on LTB4
release by AM stimulated with zymosan. The effect of treatment of AM with soluble ,B-glucans (laminarin) was specific for zymosan because laminarin did not inhibit AM release of LTB4 induced by LPS. In our experiments zymosan also was a stimulus for AM release of NAP-1. Release of NAP-I began at 5 h after challenge, a time when amounts of LTB4 present were declining. Thus, activation of AM ,B-glucan receptors by zymosan elicits the sequential release ofat least two neutrophil chemotaxins. AM release of these products in response to ,Bglucan mediated phagocytosis may provide the nonimmune host with the ability to initiate neutrophil activation and recruitment to the lung because ,B-glucan mediated phagocytosis occurs in the absence of opsonins (38) .
The calcium ionophore A23 187 is a carboxylic acid antibiotic which induces the influx of divalent cations across biologic membranes and the redistribution of intracellular calcium (39-41). Stimulation of human leukocytes with A23 187 results in a Ca++-dependent translocation of 5-lipoxygenase from the cytosolic compartment to a membrane-bound site (42). In this location the 5-lipoxygenase is utilized for leukotriene synthesis. In contrast to AM release of LTB4 and NAP-I induced by either LPS or zymosan, the time course and profile of mediator release from AM in response to nonphysiologic stimulation with the calcium ionophore A23 187 was distinctly different. A23 187 induced a rapid rise in the release of LTB4 that peaked by 30 min. Quantities of LTB4 present in AM supernatants decreased at subsequent time points. Nevertheless, significant amounts of LTB4 remained in AM supernatants harvested 24 h after stimulation (Fig. 4) . Activation of calcium transmembrane fluxes by calcium ionophore bypasses ligand-receptor interactions but remains a sufficient stimulus for the proliferation of human peripheral blood lymphocytes (43) and the release by these cells ofhuman immune interferon (44) . Although A23 187 is one of the most potent stimuli for leukotriene synthesis from numerous cell types, A23187 was not in our experiments an effective stimulus for NAP-I release.
The LTB4 time-release curves observed with LPS in this study demonstrated a decline in the concentration of LTB4 by 24 h, as determined by both RIA and RP-HPLC (Fig. 1) . Similarly, quantities of immunoreactive LTB4 in supernatants of zymosan-or A23 187-stimulated AM also declined by 24 h, Figs. 2 B and 4, respectively. These observations are explained by AM degradation of LTB4 (Fig. 6) . Our results are consistent with those of Schonfeld and co-workers (45) who observed that human lung macrophages obtained from minced fragments of surgical specimens of patients with bronchial carcinoma partially metabolized LTB4 after 1 h to products that are distinct from LTB4 (45). These products were completely resolved by RP-HPLC not only from LTB4 but also from its 20-OH-and 20-COOH-LTB4 w-oxidation metabolites, which result from neutrophil metabolism of LTB4. Furthermore, these metabolites were not recognized by LTB4 antisera, and they did not absorb at 280 nm (45). Their data suggest that at least one of these metabolites appeared to be a reduced form of LTB4, 5,12-dihydroxyeicosatrienoic acic (45). This product was described originally as a novel metabolite of rat mesangial cells and mouse bone marrow-derived macrophages by Kaever and colleagues (46, 47) . In our experiments analysis by RP-HPLC of supernatants from adhered AM cultured without LPS for significantly longer than 1 h, namely 24 h, in the presence of a trace amount of [3H]LTB4 revealed five radiolabeled peaks that were clearly separated from LTB4 by RP-HPLC. Resolution by RP-HPLC ofthe supernatants from AM cultured in an identicle manner but with LPS demonstrated these same five peaks and only one additional metabolite. Peak 1, which was observed in the culture media that was incubated for 24 h without AM, was found in greater proportions in supernatants from AM cultures. This peak coeluted with the two w-oxidation products of LTB4. AM cultures prepared as described in our methods routinely contain > 95% macrophages and < 0.5% neutrophils. However, we cannot rule out the possibility that the small numbers of cells that contaminated the AM cultures, or the macrophages themselves, may have contributed to the metabolism of LTB4 over the 24 h in culture. Thus, our results extend those of Schonfeld and co-workers (45) by revealing that human alveolar macrophages from normal subjects also metabolize LTB4. The precise identity of these metabolites has not been determined. Additional experiments will be needed to identify and functionally evaluate these novel macrophage products. For example, we have not determined whether or not the metabolites of LTB4 present in 24-h supernatants might contribute to the overall chemotactic activity observed. In this regard Kaever and colleagues (47) have determined that dihydro-LTB4 is significantly less chemotactic for human leukocytes than is LTB4.
Thirdly, our data offer at least a partial explanation for previous and discrepant observations by others on human AM-derived neutrophil chemotaxins elicited in vitro. Merrill and colleagues (48) found neutrophil chemotaxins with molecular weights of about 10,000 and < 1,000 daltons in 24-h culture fluids of human AM. Based on our data, the larger molecule was probably NAP-1. The smaller molecule, which was detected in concentrated fluids, may have been a small amount of LTB4 still present at the 24-h time point. The unidentified lipid molecule found by Hunninghake and colleagues (49) in culture fluids of AM stimulated with a variety of physiologically relevant stimuli may also have been LTB4. Recently, Martin and colleagues (13) concluded that LTB4 is the predominant chemotaxin in culture fluids of human AM stimulated with A23187 or opsonized zymosan. Our results agree with their A23187 data, since the calcium ionophore did not stimulate NAP-1 secretion. One possible explanation for the fact that Martin and colleagues (13) did not detect NAP-I in supernatants of AM incubated with NDGA and stimulated for 24 h with opsonized zymosan may be explained by our observation that NDGA at the concentrations used in both our studies, 10-4 M, completely blocks not only LTB4 release but also NAP-I release (Fig. 5) .
We believe for several reasons that it is premature to conclude that LTB4 is the only important neutrophil chemotaxin with functional activity released from AM at early time points and that NAP-I is the only important neutrophil chemotaxin present at 24 h. First, AM cultured in vitro and purposefully stimulated also release 5-HETE (9, 10, 12). We did not assess our supernatants for the presence of this product. Secondly, adhered AM from normal subjects release an inhibitor of neutrophil chemotaxis that can be detected in supernatants as little as thirty minutes after cultures are established (50) . Thirdly, we showed previously that NAP-1 does not account for all the chemotactic activity in 24-h culture fluids of LPSstimulated AM (27) . Thus, the neutrophil chemotactic activity time curve that results from AM stimulated in vitro is most likely the result of the cumulative effects of many factors that are present in AM supernatants at varying concentrations and at varying time points.
